MUNICH, April 18, 2026 /PRNewswire/ -- The largest real-world study of its kind, presented today at ESCMID Global 2026, shows that maternal vaccination against respiratory syncytial virus (RSV) reduces the risk of hospitalisation in young infants by over 80% when given at least two weeks...
Hence then, the article about escmid global maternal rsv vaccination cuts infant hospitalisation risk by over 80 major ukhsa study finds was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( ESCMID Global: Maternal RSV vaccination cuts infant hospitalisation risk by over 80%, major UKHSA study finds )
Also on site :
- Canaan Inc. Announces New US$20 Million Share Repurchase Program Under US$100 Million Board Authorization
- Huawei erkend als leider in het Gartner® Magic Quadrant™ 2026 voor Infrastructure Platform Consumption Services
- Bitmine Immersion Technologies (BMNR) annonce que ses avoirs en ETH atteignent 6,07 millions de tokens, et que ses avoirs totaux en cryptomonnaies et en liquidités et titres négociables s'élèvent à 14,3 milliards de dollars